Bizarre Patents
A fork with timer for providing a cue to a user after an elapsed period of time for indicating that another bite of food using the fork may be taken.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20080146540 | Methods of diagnosis and treatment for asthma, allergic rhinitis and other respiratory diseases based on haplotype association Methods for diagnosis of asthma or allergic rhinitis or a susceptibility to asthma or allergic rhinitis based on detection of at-risk haplotypes associated with MAP3K9 are disclosed. Also methods for treatment of asthma or allergic rhinitis or a susceptibility to asthma... | 06/19/2008 |
| 20070280917 | Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment Polymorphisms in the FLAP and LTA4H gene are shown by genetic association analysis to be susceptibility markers for myocardial infarction (MI) and ACS, as well as stroke and PAOD. Pathway targeting for treatment and diagnostic applications in identifying those who are a... | 12/06/2007 |
| 20060257481 | Sustained release formulation and dosing schedule of leukotriene synthesis inhibitor for human therapy The invention relates to improved materials and methods for therapy to inhibit production of leukotrienes, and all therapeutic applications thereof. ... | 11/16/2006 |
| 20060019269 | Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment Linkage of myocardial infarction (MI) and a locus on chromosome 13q12 is disclosed. In particular, the FLAP gene within this locus is shown by genetic association analysis to be a susceptibility gene for MI and ACS, as well as stroke and PAOD. Pathway targeting for trea... | 01/26/2006 |
| 20060014165 | Methods of diagnosis and treatment for asthma and other respiratory diseases based on haplotype association Methods for diagnosis of asthma or a susceptibility to asthma based on detection of at-risk haplotypes associated with MAP3K9 are disclosed. Also methods for treatment of asthma or a susceptibility to asthma based on detection of at-risk haplotypes associated with MAP3K... | 01/19/2006 |
| 20050282855 | Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment Linkage of myocardial infarction (MI) and a locus on chromosome 13q12 is disclosed. In particular, the FLAP gene within this locus is shown by genetic association analysis to be a susceptibility gene for MI and ACS, as well as stroke and PAOD. Pathway targeting for trea... | 12/22/2005 |
| 20050272051 | Methods of preventing or treating recurrence of myocardial infarction Linkage of myocardial infarction (MI) with a locus on chromosome 12q23 is disclosed. In particular, the LTA4H gene within this locus is shown by association analysis to be a susceptibility gene for MI. Methods for preventing and/or treating the recurrence of MI, in part... | 12/08/2005 |
| 20050191272 | Methods for producing Ex vivo models for inflammatory disease and uses thereof The invention relates to methods for inducing a pro-asthma/pro-inflammatory like state in a resident tissue cell, comprising contacting the cell with one or more cytokines, e.g., IL-1β, TNFα or both. Methods are also disclosed for identifying genes that regulate respo... | 09/01/2005 |
| 20050113408 | Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment Linkage of myocardial infarction (MI) and a locus on chromosome 13q12 is disclosed. In particular, the FLAP gene within this locus is shown by genetic association analysis to be a susceptibility gene for MI and ACS, as well as stroke and PAOD. Pathway targeting for trea... | 05/26/2005 |
| 20050032096 | Methods for predicting drug sensitivity in patients afflicted with hypertension Methods are disclosed for predicting the efficacy of a drug for treating hypertension in a patient, including: obtaining a sample of cells from the patient; obtaining a gene expression profile from the sample in the absence and presence of in vitro modulation of the cel... | 02/10/2005 |
